172 related articles for article (PubMed ID: 10439339)
1. Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations.
Warbrick EV; Dearman RJ; Lea LJ; Basketter DA; Kimber I
J Appl Toxicol; 1999; 19(4):255-60. PubMed ID: 10439339
[TBL] [Abstract][Full Text] [Related]
2. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses.
Basketter DA; Lea LJ; Dickens A; Briggs D; Pate I; Dearman RJ; Kimber I
J Appl Toxicol; 1999; 19(4):261-6. PubMed ID: 10439340
[TBL] [Abstract][Full Text] [Related]
3. Human potency predictions for aldehydes using the local lymph node assay.
Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR
Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118
[TBL] [Abstract][Full Text] [Related]
4. Influence of application vehicle on skin sensitization to methylchloroisothiazolinone/methylisothiazolinone: an analysis using the local lymph node assay.
Warbrick EV; Dearman RJ; Basketter DA; Kimber I
Contact Dermatitis; 1999 Dec; 41(6):325-9. PubMed ID: 10617213
[TBL] [Abstract][Full Text] [Related]
5. Temporal stability of local lymph node assay responses to hexyl cinnamic aldehyde.
Dearman RJ; Hilton J; Evans P; Harvey P; Basketter DA; Kimber I
J Appl Toxicol; 1998; 18(4):281-4. PubMed ID: 9719428
[TBL] [Abstract][Full Text] [Related]
6. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
7. The suitability of hexyl cinnamic aldehyde as a calibrant for the murine local lymph node assay.
Dearman RJ; Wright ZM; Basketter DA; Ryan CA; Gerberick GF; Kimber I
Contact Dermatitis; 2001 Jun; 44(6):357-61. PubMed ID: 11380546
[TBL] [Abstract][Full Text] [Related]
8. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
9. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
Hilton J; Dearman RJ; Harvey P; Evans P; Basketter DA; Kimber I
Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the skin sensitization potential of topical medicaments using the local lymph node assay: an interlaboratory evaluation.
Kimber I; Hilton J; Dearman RJ; Gerberick GF; Ryan CA; Basketter DA; Lea L; House RV; Ladics GS; Loveless SE; Hastings KL
J Toxicol Environ Health A; 1998 Apr; 53(7):563-79. PubMed ID: 9561969
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
12. Cytokine endpoints for the local lymph node assay: consideration of interferon-gamma and interleukin 12.
Dearman RJ; Hilton J; Basketter DA; Kimber I
J Appl Toxicol; 1999; 19(3):149-55. PubMed ID: 10362264
[TBL] [Abstract][Full Text] [Related]
13. The murine local lymph node assay: results of an inter-laboratory trial.
Kimber I; Hilton J; Botham PA; Basketter DA; Scholes EW; Miller K; Robbins MC; Harrison PT; Gray TJ; Waite SJ
Toxicol Lett; 1991 Feb; 55(2):203-13. PubMed ID: 1998208
[TBL] [Abstract][Full Text] [Related]
14. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
15. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
[TBL] [Abstract][Full Text] [Related]
16. Skin sensitization testing in potency and risk assessment.
Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
[TBL] [Abstract][Full Text] [Related]
17. The local lymph node assay and potential application to the identification of drug allergens.
Kimber I
Toxicology; 2001 Feb; 158(1-2):59-64. PubMed ID: 11164993
[TBL] [Abstract][Full Text] [Related]
18. Introduction of a methoxymethyl side chain into p-phenylenediamine attenuates its sensitizing potency and reduces the risk of allergy induction.
Goebel C; Troutman J; Hennen J; Rothe H; Schlatter H; Gerberick GF; Blömeke B
Toxicol Appl Pharmacol; 2014 Feb; 274(3):480-7. PubMed ID: 24333256
[TBL] [Abstract][Full Text] [Related]
19. Intralaboratory validation of alternative endpoints in the murine local lymph node assay for the identification of contact allergic potential: primary ear skin irritation and ear-draining lymph node hyperplasia induced by topical chemicals.
Ulrich P; Streich J; Suter W
Arch Toxicol; 2001 Feb; 74(12):733-44. PubMed ID: 11305775
[TBL] [Abstract][Full Text] [Related]
20. Advantage of using CBA/N strain mice in a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamasaki K; Kimber I
J Appl Toxicol; 2006; 26(1):5-9. PubMed ID: 16217858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
